Ameriprise’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Buy |
110,456
+91,211
| +474% | +$2.37M | ﹤0.01% | 2738 |
|
|
2025
Q1 | $471K | Sell |
19,245
-2,701
| -12% | -$66.1K | ﹤0.01% | 3479 |
|
|
2024
Q4 | $629K | Buy |
21,946
+9,051
| +70% | +$260K | ﹤0.01% | 3407 |
|
|
2024
Q3 | $487K | Buy |
12,895
+2,419
| +23% | +$91.3K | ﹤0.01% | 3474 |
|
|
2024
Q2 | $331K | Buy |
+10,476
| New | +$331K | ﹤0.01% | 3563 |
|